Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000686410 | SCV000813928 | benign | Tuberous sclerosis 2 | 2023-12-13 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV001016871 | SCV001177872 | uncertain significance | Hereditary cancer-predisposing syndrome | 2022-08-26 | criteria provided, single submitter | clinical testing | The p.N959K variant (also known as c.2877C>G), located in coding exon 25 of the TSC2 gene, results from a C to G substitution at nucleotide position 2877. The asparagine at codon 959 is replaced by lysine, an amino acid with similar properties. This amino acid position is not well conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Genome- |
RCV000686410 | SCV002040730 | uncertain significance | Tuberous sclerosis 2 | 2021-11-07 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV003465558 | SCV004205128 | uncertain significance | Isolated focal cortical dysplasia type II | 2024-02-08 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV004004248 | SCV004828274 | uncertain significance | Tuberous sclerosis syndrome | 2023-05-30 | criteria provided, single submitter | clinical testing | This missense variant replaces asparagine with lysine at codon 959 of the TSC2 protein. Computational prediction suggests that this variant may not impact protein structure and function (internally defined REVEL score threshold <= 0.5, PMID: 27666373). To our knowledge, functional studies have not been reported for this variant. This variant has not been reported in individuals affected with TSC2-related disorders in the literature. This variant has been identified in 1/31396 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. |